Global Brand Lead, Navtemadlin

Title: Global Brand Lead, Navtemadlin Company: Ipsen Biopharmaceuticals Inc. About Ipsen: Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

For more information, visit us at https://www.ipsen.com/   and follow our latest news on LinkedIn and Instagram . Job Description: The Global Brand Lead, Navtemadlin (GBL, Nav) is a senior commercial leader responsible for shaping and delivering the brand strategy for Navtemadlin, a Phase 3 oncology therapeutic in late-stage development. Based in the US, this role leads integrated brand planning, translates asset strategy into clear commercial priorities, and mobilizes cross-functional global, regional, and US teams to support late-stage development, launch readiness, and long-term brand value.

Reporting to the Asset Lead, Navtemadlin, the GBL is especially critical where disciplined late-stage development planning, strong launch execution, and deep understanding of the US oncology market are required. The Brand Lead will bring strategic marketing expertise, strong scientific and commercial acumen, and the ability to lead through influence across Medical, Market Access, Regulatory, Insights, Finance, Supply, Legal, Business Ethics, Digital / Customer Experience, and priority affiliate teams.

The ideal candidate is a strategic, externally oriented, and execution-focused leader with demonstrated late-stage development and launch experience in oncology; hematology experience is preferred. WHAT - Main Responsibilities Brand Strategy & Portfolio Leadership Develop and execute the integrated brand strategy for Navtemadlin to maximize long-term asset value and patient impact. Translate portfolio and asset objectives into clear commercial priorities, strategic initiatives, and measurable business outcomes.

Launch & Growth Execution Lead late-stage development commercialization planning and launch readiness activities for a Phase 3 oncology therapeutic, with a strong focus on US market requirements. Drive lifecycle management strategies that accelerate growth, expand market opportunities, and sustain brand performance. Cross-Functional Leadership Lead and influence a global matrix team across Commercial, Medical, Market Access, Regulatory, Finance, Supply Chain, and other key functions.

Build alignment across global and local stakeholders to ensure effective decision-making and execution. Customer & Market Insight Leverage customer, patient, competitor, and market insights to identify opportunities, mitigate risks, and inform strategic choices. Ensure strategies are grounded in evolving market dynamics and stakeholder needs. Performance & Governance Define performance metrics, monitor results, and drive course corrections to achieve business objectives.

Ensure all activities are executed in compliance with company policies and applicable regulations. HOW - Knowledge & Experience Education / Certifications: BA/BS (undergraduate degree) in business or life sciences is required MBA or advanced degree is preferred. Knowledge & Experience (essential): 15+ years of experience in the pharmaceutical or biotechnology industry, including global or regional marketing, brand strategy, asset strategy and launch leade